Wissenschaft trifft Wirtschaft

"EmbryoNet: Revolutionising drug development through AI-driven analysis of embryonic developmental defects"

Insights into AI-powered technologies that can automatically identify and classify developmental defects in vertebrate embryos. These technologies not only offer new insights into the mechanisms of action of drugs, but also have the potential to fundamentally transform the drug development process by enabling precise and efficient analyses of the underlying signalling pathways.

Prof. Dr. Patrick Müller (Biologie)

More information: Homepage

Datum: 13.06.2024